Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.0%

11 terminated/withdrawn out of 122 trials

Success Rate

90.3%

+3.8% vs industry average

Late-Stage Pipeline

30%

36 trials in Phase 3/4

Results Transparency

3%

3 of 102 completed trials have results

Key Signals

1 recruiting3 with results9 terminated

Enrollment Performance

Analytics

N/A
47(51.1%)
Phase 4
27(29.3%)
Phase 3
9(9.8%)
Phase 2
5(5.4%)
Phase 1
3(3.3%)
Early Phase 1
1(1.1%)
92Total
N/A(47)
Phase 4(27)
Phase 3(9)
Phase 2(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (122)

Showing 20 of 122 trials
NCT05278780Not ApplicableCompleted

Medication Abortion With Autonomous Self-Assessment Project

Role: lead

NCT05459142Completed

Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan.

Role: lead

NCT05781061Not ApplicableCompleted

MA-ASAP at Independent Abortion Clinics: A Demonstration Project

Role: lead

NCT05028387Completed

Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.

Role: lead

NCT03749902Phase 4Completed

A Randomized Trial of Oral Misoprostol Alone Versus Oral Misoprostol Followed by Oxytocin for Labour Induction

Role: collaborator

NCT06270056Recruiting

Evaluation of Telemedicine Medical Abortion Service in Ecuador

Role: lead

NCT06492889Phase 2Not Yet Recruiting

Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens

Role: lead

NCT03931460Completed

Feasibility of Medical Abortion by Telemedicine in Mexico

Role: lead

NCT05119439Phase 4Terminated

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Role: lead

NCT05207644Phase 2Completed

Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation

Role: lead

NCT04037683Completed

qMOLI- A Qualitative Assessment of Misoprostol or Oxytocin for Labour Induction

Role: collaborator

NCT02513043Completed

Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

Role: lead

NCT04599725Completed

Feasibility of Telemedicine Medical Abortion

Role: lead

NCT04316325Completed

Medical Abortion Via Telemedicine for Women and Adolescents in Moldova

Role: collaborator

NCT05046041Phase 4Completed

Assessing Outpatient 'Day Procedure' for Second-trimester Medical Abortion at Two Public Sector Hospitals in Nepal

Role: lead

NCT04676776Phase 2Unknown

Assessing Use Of Mifepristone After Progestin Priming For Use As "Missed Period Pills"

Role: lead

NCT02704481Phase 4Terminated

Non-surgical Alternatives to Treatment of Failed Medical Abortion

Role: lead

NCT03552055Completed

Urine and Serum Concentrations of Pregnancy-Associated Compounds During Gestation

Role: lead

NCT04232189Terminated

Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion

Role: lead

NCT04063904Phase 4Terminated

Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Role: lead